MAPT and Alzheimer disease: Alzheimer's disease (AD) is characterized by amyloid‐beta (Aβ), hyperphosphorylated tau, chronic neuroinflammation, blood–brain barrier (BBB) damage, and synaptic dysfunction, leading to neuronal loss and cognitive deficits.